These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 2163279)

  • 1. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
    Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
    Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet-activating factor- and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate.
    Bruijnzeel PL; Warringa RA; Kok PT
    Br J Pharmacol; 1989 Aug; 97(4):1251-7. PubMed ID: 2551444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of nedocromil sodium on the in vitro induced migration and leukotriene formation of human granulocytes.
    Bruijnzeel PL; Warringa RA; Kok PT; Hamelink ML; Kreukniet J
    Drugs; 1989; 37 Suppl 1():9-18; discussion 69-77. PubMed ID: 2547570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
    Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
    J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes.
    Bruijnzeel PL; Warringa RA; Kok PT; Hamelink ML; Kreukniet H; Koenderman L
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 2):159-64. PubMed ID: 8393021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nedocromil sodium and WEB 2086 on chemoattractant-stimulated neutrophil migration through cellular and noncellular barriers.
    Carolan EJ; Casale TB
    Ann Allergy; 1992 Oct; 69(4):323-8. PubMed ID: 1329582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cytokine-primed eosinophil chemotaxis by nedocromil sodium.
    Warringa RA; Mengelers HJ; Maikoe T; Bruijnzeel PL; Koenderman L
    J Allergy Clin Immunol; 1993 Mar; 91(3):802-9. PubMed ID: 8384226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins.
    Morita E; Schröder JM; Christophers E
    Scand J Immunol; 1989 Jun; 29(6):709-16. PubMed ID: 2544988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nedocromil sodium on the binding of N-formyl-methionyl-leucyl-phenylalanine in human neutrophils.
    Peroni DG; Melotti P; Piacentini GL; Bonizzato C; Boner AL
    Agents Actions; 1992 Jul; 36(3-4):212-4. PubMed ID: 1326878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nedocromil sodium inhibits the A23187- and opsonized zymosan-induced leukotriene formation by human eosinophils but not by human neutrophils.
    Bruijnzeel PL; Hamelink ML; Kok PT; Kreukniet J
    Br J Pharmacol; 1989 Mar; 96(3):631-6. PubMed ID: 2541846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro.
    Hidi R; Coëffier E; Vargaftig BB
    J Leukoc Biol; 1992 May; 51(5):425-31. PubMed ID: 1318347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of nedocromil sodium on human eosinophil activation.
    Moqbel R; Cromwell O; Kay AB
    Drugs; 1989; 37 Suppl 1():19-22; discussion 69-77. PubMed ID: 2547563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
    Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
    Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
    Erger RA; Casale TB
    Am J Respir Cell Mol Biol; 1995 Jan; 12(1):65-70. PubMed ID: 7811471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LTB4, a potent chemotactic factor for purified guinea-pig eosinophils: interference of PAF-acether antagonists.
    Coëffier E; Joseph D; Vargaftig BB
    Int J Immunopharmacol; 1991; 13(2-3):273-80. PubMed ID: 1649143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
    Tamura N; Agrawal DK; Suliaman FA; Townley RG
    Biochem Biophys Res Commun; 1987 Feb; 142(3):638-44. PubMed ID: 3030295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate.
    Tool AT; Verhoeven AJ
    Arzneimittelforschung; 1995 Oct; 45(10):1110-4. PubMed ID: 8595070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nedocromil sodium prevents in vivo generation of the eosinophilotactic substance induced by PAF but fails to antagonize its effects.
    e Silva PM; Martins MA; Castro-Faria-Neto HC; Bozza PT; Pires AL; Cordeiro RS; Vargaftig BB
    Br J Pharmacol; 1992 Feb; 105(2):436-40. PubMed ID: 1313729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Warringa RA; Koenderman L; Kok PT; Kreukniet J; Bruijnzeel PL
    Blood; 1991 Jun; 77(12):2694-700. PubMed ID: 1646045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
    Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.